Radiotherapy Market Analysis and Forecast to 2033: By Type (External Beam Radiation Therapy {Intensity-Modulated Radiation Therapy [IMRT], Image-Guided Radiation Therapy [IGRT], Proton Therapy}, Internal Radiation Therapy, Systemic Radiation Therapy), By

Radiotherapy Market Analysis and Forecast to 2033: By Type (External Beam Radiation Therapy {Intensity-Modulated Radiation Therapy [IMRT], Image-Guided Radiation Therapy [IGRT], Proton Therapy}, Internal Radiation Therapy, Systemic Radiation Therapy), By Application (Lung Cancer, Prostate Cancer, Breast Cancer, Cervical Cancer, Head & Neck Cancer), By End-use (Hospitals, Radiotherapy Centers & Ambulatory Surgery Centers, Cancer Research Institutes), and Region


The global radiotherapy market was valued at USD 7.3 billion in 2023 and it is anticipated to grow up to USD 12.5 billion by 2033, at a CAGR of 5.4% during the forecast period.

Radiotherapy, commonly known as radiation therapy, is used for cancer patients to cure cancer by destroying the cancer cells and reducing the size of tumors. X-rays, gamma rays, and charged particles are commonly used radiotherapy markets during radiotherapy. Modern radiotherapy makes use of highly precise collimating devices that positively impacts the market expansion.

Global Radiotherapy Market Scope and Report Structure

Market Trends and Drivers


Rising number of cancer cases is expected to accelerate the market growth Surging number of cancer cases worldwide is expected to foster the market demand for radiotherapy over the analysis timeframe. According to the WHO, cancer is the leading cause of death globally and around ten million deaths occurred in 2020. Breast, prostate, lung, colon and rectum are among the most common cancers that further accelerates the market progress for radiotherapy. Similarly, according to International Agency for Research on Cancer (IARC), over seventeen million new cancer cases across the globe were observed in 2018. And by 2040, it is projected to grow to 27.5 million new cases. Therefore, radiotherapy is the most common method used to treat cancer and ease the symptoms of cancer and further slows or stops the growth of damaged cells. Hence, aforementioned aspects will prove beneficial for the overall market progression.

Market Restraints and Challenges


Difficulties in visualizing tumors during radiotherapy procedures may impede the market growth. One of the major challenges faced during radiotherapy procedures is difficulties faced in the visualization of tumors and demarcations from normal healthy tissues. Advancements in ionizing radiation therapy for cancer treatment are expected to help overcome this challenge. However, since tumors can change their shape daily, it becomes difficult to only radiate the cancerous outgrowth without affecting the surrounding tissues. To limit this, radiologists include a safety margin around the tumor. Also, to minimize the damage to the surrounding healthy tissue, it becomes a compulsion to limit the radiotherapy dose range, increasing the number of treatment cycles needed to eradicate tumorous cells. This is one of the major factors responsible for increasing the cancer treatment costs for patients undergoing radiotherapy.

Global Radiotherapy Market Segmental Overview


The report analyses the global radiotherapy market based on type, application, end use, and region.

Global Radiotherapy Market by Type

Based on type, the radiotherapy market is

Global Radiotherapy Market by Application

On the basis of application, the radiotherapy market is segmented into head & neck cancer, breast cancer, lung cancer, prostate cancer and cervical cancer among others. Among them, the breast cancer segment accounted for significant revenue size in 2023. Radiation therapy is used at every stage to treat breast cancer and uses protons, X-rays or other particles to kill cancer cells. Radiotherapy for breast cancer can be effectively delivered through external radiation and internal radiation or brachytherapy that secures the market progress. Further, this therapy is one of the effective ways to reduce the risk of breast cancer post-surgery and also ease the symptoms caused by cancer. As per the World Health Organization (WHO) data, in 2020, 2.3 million women were diagnosed with breast cancer and as the end of 2020, nearly 7.8 million women were diagnosed and recorded with breast cancer in the past 5 years. Thus, rising demand for advanced and innovative treatments for breast cancer will enhance the overall market demand.

Global Radiotherapy Market by End-use

Based on end-use, the industry is categorized into hospitals, radiotherapy centers & ambulatory surgery centers as well as cancer research institutes. The hospitals segment accounted for over 41% market share in 2023. Hospitals act as one of the first point of contact for the treatment of cancer. Rising number of cancer cases for better treatment options under skillful healthcare professionals will foster the industry progression. Furthermore, hospitals are equipped with advanced healthcare facilities and devices for effective patient management and care that further enhances the overall market trends.

Geographical Analysis of Global Radiotherapy Market


Region-wise, it is studied across North America, Europe, Asia Pacific, and the Rest of the World. North America radiotherapy industry captured largest market share in 2023 and is poised to grow substantially during the forthcoming years. High regional growth is attributed to increasing healthcare infrastructure and R&D investments across the region. The regional market is inclined towards funding and early diagnosis & treatment of cancer with its significant measures, instruments, and infrastructure of hospitals or other centers. Presence of several market participants focusing on developing innovative products for better patient management will prove advantageous for the market expansion. Similarly, increasing geriatric population requiring better treatment and favorable government initiatives will accelerate the regional industry statistics.

Major Players in the Global Radiotherapy Market



Please Note:This report will be delivered by publisher within 3-4 business days of order confirmation.


Chapter 1. Market Introduction
1.1. Objectives of The Study
1.2. Market Definition And Research & Scope
1.3. Research Methodologies
1.4. Market Estimation Techniques
Chapter 2. Executive Summary
2.1. Summary
2.2. Key Highlights of The Market
Chapter 3. Radiotherapy Market Outlook
3.1. Radiotherapy Market Segmentation
3.2. Market Dynamics
3.2.1. Market Drivers
3.2.1.1. Driver 1
3.2.1.2. Driver 2
3.2.1.3. Driver 3
3.2.2. Market Restraints
3.2.2.1. Restraint 1
3.2.2.2. Restraint 2
3.2.3. Market Opportunities
3.2.3.1. Opportunity 1
3.2.3.2. Opportunity 2
3.3. Porter’s Five Forces Analysis
3.3.1. Threat of New Entrants
3.3.2. Threat of Substitutes
3.3.3. Bargaining Power of Buyers
3.3.4. Bargaining Power of Supplier
3.3.5. Competitive Rivalry
3.4. Pestle Analysis
3.5. Value Chain Analysis
3.5.1. Raw Material Suppliers
3.5.2. Manufacturers
3.5.3. Wholesalers and/or Retailers
3.6. Impact of The Russia And Ukraine War on The Radiotherapy Market
Chapter 4. The Economic Impact of COVID-19
4.1. Overall Impact of COVID-19
4.2. Impact of COVID-19 on the Radiotherapy Market
4.3. Economic Impact Analysis
Chapter 5. Radiotherapy Market by Product
5.1. Market Overview
5.2. External Beam Radiation Therapy
5.2.1. Market Size And Forecast
5.2.2. Market Size And Forecast, by Region
5.2.2.1. Intensity-Modulated Radiation Therapy (IMRT)
5.2.2.1.1.1. Market Size And Forecast
5.2.2.1.1.2. Market Size And Forecast, by Region
5.2.2.2. Image-Guided Radiation Therapy (IGRT)
5.2.2.2.1.1. Market Size And Forecast
5.2.2.2.1.2. Market Size And Forecast, by Region
5.2.2.3. Proton Therapy
5.2.2.3.1.1. Market Size And Forecast
5.2.2.3.1.2. Market Size And Forecast, by Region
5.2.2.4. Others
5.2.2.4.1.1. Market Size And Forecast
5.2.2.4.1.2. Market Size And Forecast, by Region
5.3. Internal Radiation Therapy
5.3.1. Market Size And Forecast
5.3.2. Market Size And Forecast, by Region
5.4. Systemic Radiation Therapy
5.4.1. Market Size And Forecast
5.4.2. Market Size And Forecast, by Region
Chapter 6. Radiotherapy Market by Application
6.1. Market Overview
6.2. Lung Cancer
6.2.1. Market Size And Forecast
6.2.2. Market Size And Forecast, by Region
6.3. Prostate Cancer
6.3.1. Market Size And Forecast
6.3.2. Market Size And Forecast, by Region
6.4. Breast Cancer
6.4.1. Market Size And Forecast
6.4.2. Market Size And Forecast, by Region
6.5. Cervical Cancer
6.5.1. Market Size And Forecast
6.5.2. Market Size And Forecast, by Region
6.6. Head & Neck Cancer
6.6.1. Market Size And Forecast
6.6.2. Market Size And Forecast, by Region
6.7. Others
6.7.1. Market Size And Forecast
6.7.2. Market Size And Forecast, by Region
Chapter 7. Radiotherapy Market by End-use
7.1. Market Overview
7.2. Hospitals
7.2.1. Market Size And Forecast
7.2.2. Market Size And Forecast, by Region
7.3. Radiotherapy Centers & Ambulatory Surgery Centers
7.3.1. Market Size And Forecast
7.3.2. Market Size And Forecast, by Region
7.4. Cancer Research Institutes
7.4.1. Market Size And Forecast
7.4.2. Market Size And Forecast, by Region
Chapter 8. Radiotherapy Market , by Region
8.1. Overview
8.2. North America
8.2.1. Key Market Trends And Opportunities
8.2.2. North America Radiotherapy Market Size And Forecast by Product, ($Million)
8.2.2.1. North America Radiotherapy Market Size And Forecast by External Beam Radiation Therapy, ($Million)
8.2.3. North America Radiotherapy Market Size And Forecast by Application, ($Million)
8.2.4. North America Radiotherapy Market Size And Forecast by End-use, ($Million)
8.2.5. North America Radiotherapy Market Size And Forecast by Country, ($Million)
8.2.6. The U.S.
8.2.6.1. The U.S. Radiotherapy Market Size And Forecast by Product, ($Million)
8.2.6.1.1. The U.S. Radiotherapy Market Size And Forecast by External Beam Radiation Therapy, ($Million)
8.2.6.2. The U.S. Radiotherapy Market Size And Forecast by Application, ($Million)
8.2.6.3. The U.S. Radiotherapy Market Size And Forecast by End-use, ($Million)
8.2.7. Canada
8.2.7.1. Canada Radiotherapy Market Size And Forecast by Product, ($Million)
8.2.7.1.1. Canada Radiotherapy Market Size And Forecast by External Beam Radiation Therapy, ($Million)
8.2.7.2. Canada Radiotherapy Market Size And Forecast by Application, ($Million)
8.2.7.3. Canada Radiotherapy Market Size And Forecast by End-use, ($Million)
8.2.8. Mexico
8.2.8.1. Mexico Radiotherapy Market Size And Forecast by Product, ($Million)
8.2.8.1.1. Mexico Radiotherapy Market Size And Forecast by External Beam Radiation Therapy, ($Million)
8.2.8.2. Mexico Radiotherapy Market Size And Forecast by Application, ($Million)
8.2.8.3. Mexico Radiotherapy Market Size And Forecast by End-use, ($Million)
8.3. Europe
8.3.1. Key Market Trends And Opportunities
8.3.2. Europe Radiotherapy Market Size And Forecast by Product, ($Million)
8.3.2.1. Europe Radiotherapy Market Size And Forecast by External Beam Radiation Therapy, ($Million)
8.3.3. Europe Radiotherapy Market Size And Forecast by Application, ($Million)
8.3.4. Europe Radiotherapy Market Size And Forecast by End-use, ($Million)
8.3.5. Europe Radiotherapy Market Size And Forecast by Country, ($Million)
8.3.5.1. Germany
8.3.5.2. Germany Radiotherapy Market Size And Forecast by Product, ($Million)
8.3.5.2.1. Germany Radiotherapy Market Size And Forecast by External Beam Radiation Therapy, ($Million)
8.3.5.2.2. Germany Radiotherapy Market Size And Forecast by Application, ($Million)
8.3.5.3. Germany Radiotherapy Market Size And Forecast by End-use, ($Million)
8.3.6. France
8.3.6.1. France Radiotherapy Market Size And Forecast by Product, ($Million)
8.3.6.1.1. France Radiotherapy Market Size And Forecast by External Beam Radiation Therapy, ($Million)
8.3.6.2. France Radiotherapy Market Size And Forecast by Application, ($Million)
8.3.6.3. France Radiotherapy Market Size And Forecast by End-use, ($Million)
8.3.7. U.K
8.3.7.1. U.K. Radiotherapy Market Size And Forecast by Product, ($Million)
8.3.7.1.1. U.K. Radiotherapy Market Size And Forecast by External Beam Radiation Therapy, ($Million)
8.3.7.2. U.K. Radiotherapy Market Size And Forecast by Application, ($Million)
8.3.7.3. U.K. Radiotherapy Market Size And Forecast by End-use, ($Million)
8.3.8. Spain
8.3.8.1. Spain Radiotherapy Market Size And Forecast by Product, ($Million)
8.3.8.1.1. Spain Radiotherapy Market Size And Forecast by External Beam Radiation Therapy, ($Million)
8.3.8.2. Spain Radiotherapy Market Size And Forecast by Application, ($Million)
8.3.8.3. Spain Radiotherapy Market Size And Forecast by End-use, ($Million)
8.3.9. Italy
8.3.9.1. Italy Radiotherapy Market Size And Forecast by Product, ($Million)
8.3.9.1.1. Italy Radiotherapy Market Size And Forecast by External Beam Radiation Therapy, ($Million)
8.3.9.2. Italy Radiotherapy Market Size And Forecast by Application, ($Million)
8.3.9.3. Italy Radiotherapy Market Size And Forecast by End-use, ($Million)
8.3.10. Russia
8.3.10.1. Russia Radiotherapy Market Size And Forecast by Product, ($Million)
8.3.10.1.1. Russia Radiotherapy Market Size And Forecast by External Beam Radiation Therapy, ($Million)
8.3.10.2. Russia Radiotherapy Market Size And Forecast by Application, ($Million)
8.3.10.3. Russia Radiotherapy Market Size And Forecast by End-use, ($Million)
8.3.11. Rest of Europe
8.3.11.1. Rest of Europe Radiotherapy Market Size And Forecast by Product, ($Million)
8.3.11.1.1. Rest of Europe Radiotherapy Market Size And Forecast by External Beam Radiation Therapy, ($Million)
8.3.11.2. Rest of Europe Radiotherapy Market Size And Forecast by Application, ($Million)
8.3.11.3. Rest of Europe Radiotherapy Market Size And Forecast by End-use, ($Million)
8.4. Asia-Pacific
8.4.1. Key Market Trends And Opportunities
8.4.2. Asia-Pacific Radiotherapy Market Size And Forecast by Country, ($Million)
8.4.2.1. Asia-Pacific Radiotherapy Market Size And Forecast by External Beam Radiation Therapy, ($Million)
8.4.3. Asia-Pacific Radiotherapy Market Size And Forecast by Application, ($Million)
8.4.4. Asia-Pacific Radiotherapy Market Size And Forecast by End-use, ($Million)
8.4.5. China
8.4.5.1. China Radiotherapy Market Size And Forecast by Product, ($Million)
8.4.5.1.1. China Radiotherapy Market Size And Forecast by External Beam Radiation Therapy, ($Million)
8.4.5.2. China Radiotherapy Market Size And Forecast by Application, ($Million)
8.4.5.3. China Radiotherapy Market Size And Forecast by End-use, ($Million)
8.4.6. India
8.4.6.1. India Radiotherapy Market Size And Forecast by Product, ($Million)
8.4.6.1.1. India Radiotherapy Market Size And Forecast by External Beam Radiation Therapy, ($Million)
8.4.6.2. India Radiotherapy Market Size And Forecast by Application, ($Million)
8.4.6.3. India Radiotherapy Market Size And Forecast by End-use, ($Million)
8.4.7. Japan
8.4.7.1. Japan Radiotherapy Market Size And Forecast by Product, ($Million)
8.4.7.1.1. Japan Radiotherapy Market Size And Forecast by External Beam Radiation Therapy, ($Million)
8.4.7.2. Japan Radiotherapy Market Size And Forecast by Application, ($Million)
8.4.7.3. Japan Radiotherapy Market Size And Forecast by End-use, ($Million)
8.4.8. South Korea
8.4.8.1. South Korea Radiotherapy Market Size And Forecast by Product, ($Million)
8.4.8.1.1. South Korea Radiotherapy Market Size And Forecast by External Beam Radiation Therapy, ($Million)
8.4.8.2. South Korea Radiotherapy Market Size And Forecast by Application, ($Million)
8.4.8.3. South Korea Radiotherapy Market Size And Forecast by End-use, ($Million)
8.4.9. Rest of APAC
8.4.9.1. Rest of APAC Radiotherapy Market Size And Forecast by Product, ($Million)
8.4.9.1.1. Rest of APAC Radiotherapy Market Size And Forecast by External Beam Radiation Therapy, ($Million)
8.4.9.2. Rest of APAC Radiotherapy Market Size And Forecast by Application, ($Million)
8.4.9.3. Rest of APAC Radiotherapy Market Size And Forecast by End-use, ($Million)
8.5. Rest of The World
8.5.1. Key Market Trends And Opportunities
8.5.2. Rest of The World Radiotherapy Market Size And Forecast by Product, ($Million)
8.5.2.1. Rest of The World Radiotherapy Market Size And Forecast by External Beam Radiation Therapy, ($Million)
8.5.3. Rest of The World Radiotherapy Market Size And Forecast by Application, ($Million)
8.5.4. Rest of The World Radiotherapy Market Size And Forecast by End-use, ($Million)
8.5.5. Rest of The World Radiotherapy Market Size And Forecast by Country, ($Million)
8.5.6. Latin America
8.5.6.1. Latin America Radiotherapy Market Size And Forecast by Product, ($Million)
8.5.6.1.1. Latin America Radiotherapy Market Size And Forecast by External Beam Radiation Therapy, ($Million)
8.5.6.2. Latin America Radiotherapy Market Size And Forecast by Application, ($Million)
8.5.6.3. Latin America Radiotherapy Market Size And Forecast by End-use, ($Million)
8.5.7. Middle East
8.5.7.1. Middle East Radiotherapy Market Size And Forecast by Product, ($Million)
8.5.7.1.1. Middle East Radiotherapy Market Size And Forecast by External Beam Radiation Therapy, ($Million)
8.5.7.2. Middle East Radiotherapy Market Size And Forecast by Application, ($Million)
8.5.7.3. Middle East Radiotherapy Market Size And Forecast by End-use, ($Million)
8.5.8. Africa
8.5.8.1. Africa Radiotherapy Market Size And Forecast by Product, ($Million)
8.5.8.1.1. Africa Radiotherapy Market Size And Forecast by External Beam Radiation Therapy, ($Million)
8.5.8.2. Africa Radiotherapy Market Size And Forecast by Application, ($Million)
8.5.8.3. Africa Radiotherapy Market Size And Forecast by End-use, ($Million)
Chapter 9. Competitive Landscape
9.1. Market Overview
9.2. Market Share Analysis/Key Player Positioning
9.3. Developmental Strategy Benchmarking
9.3.1. New Testing Type Development
9.3.2. Chemical-based Launches
9.3.3. Business Expansions
9.3.4. Partnerships, Joint Ventures, And Collaborations
9.3.5. Mergers And Acquisitions
Chapter 10. Company Profiles
10.1. Siemens Healthineers AG (Germany),
10.1.1. Company Snapshot
10.1.2. Financial Performance
10.1.3. Chemical-based offerings
10.1.4. Key Strategic Initiatives
10.1.5. SWOT Analysis
10.2. Elekta (Sweden)
10.2.1. Company Snapshot
10.2.2. Financial Performance
10.2.3. Chemical-based offerings
10.2.4. Key Strategic Initiatives
10.2.5. SWOT Analysis
10.3. Accuray Incorporated (US)
10.3.1. Company Snapshot
10.3.2. Financial Performance
10.3.3. Chemical-based offerings
10.3.4. Key Strategic Initiatives
10.3.5. SWOT Analysis
10.4. IBA (Belgium)
10.4.1. Company Snapshot
10.4.2. Financial Performance
10.4.3. Chemical-based offerings
10.4.4. Key Strategic Initiatives
10.4.5. SWOT Analysis
10.5. ViewRay Technologies, Inc. (US),
10.5.1. Company Snapshot
10.5.2. Financial Performance
10.5.3. Chemical-based offerings
10.5.4. Key Strategic Initiatives
10.5.5. SWOT Analysis
10.6. Hitachi Ltd. (Japan)
10.6.1. Company Snapshot
10.6.2. Financial Performance
10.6.3. Chemical-based offerings
10.6.4. Key Strategic Initiatives
10.6.5. SWOT Analysis
10.7. iCAD, Inc. (US)
10.7.1. Company Snapshot
10.7.2. Financial Performance
10.7.3. Chemical-based offerings
10.7.4. Key Strategic Initiatives
10.7.5. SWOT Analysis
10.8. ZEISS Group (Germany)
10.8.1. Company Snapshot
10.8.2. Financial Performance
10.8.3. Chemical-based offerings
10.8.4. Key Strategic Initiatives
10.8.5. SWOT Analysis
10.9. Mevion Medical Systems, Inc. (US)
10.9.1. Company Snapshot
10.9.2. Financial Performance
10.9.3. Chemical-based offerings
10.9.4. Key Strategic Initiatives
10.9.5. SWOT Analysis
10.10. Panacea Medical Technologies Pvt. Ltd. (India)
10.10.1. Company Snapshot
10.10.2. Financial Performance
10.10.3. Chemical-based offerings
10.10.4. Key Strategic Initiatives
10.10.5. SWOT Analysis
*The List of Company Is Subject To Change During The Final Compilation of The Report

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings